Campus Biotech Revenue and Competitors
Estimated Revenue & Valuation
- Campus Biotech's estimated annual revenue is currently $11.3M per year.
- Campus Biotech's estimated revenue per employee is $155,000
Employee Data
- Campus Biotech has 73 Employees.
- Campus Biotech grew their employee count by -23% last year.
Campus Biotech Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $81.4M | 375 | 40% | N/A | N/A |
#2 | $16.9M | 109 | 22% | N/A | N/A |
#3 | $156.1M | 120 | -70% | $145M | N/A |
#4 | $2.9M | 37 | -24% | $150M | N/A |
#5 | $1.3M | 17 | 0% | $459.5M | N/A |
#6 | $49.2M | 254 | 15% | $180.7M | N/A |
#7 | $7M | 45 | -2% | N/A | N/A |
#8 | $256.3M | 840 | 9% | $168.5M | N/A |
#9 | $4.2M | 27 | -7% | N/A | N/A |
#10 | $10.1M | 65 | 5% | N/A | N/A |
What Is Campus Biotech?
Campus Biotech is a new centre of excellence in biotechnology and life science research. It focuses on pure science and its translation into practical outcomes that have an impact on society and the world. Campus Biotech is expected to generate a vast range of opportunities, bringing impetus and investment to this vital economic and scientific sector.
keywords:N/A
N/A
Total Funding
73
Number of Employees
$11.3M
Revenue (est)
-23%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Campus Biotech News
Blackstone's $280 billion real-estate team is buying up everything from warehouses to campus housing to biotech lab space. Here's a look at its...
California biotech firm scouting sites in Philadelphia suburbs to develop new 200,000-square-foot campus.
... Sciences Projects Unveils Plans for San Francisco Area Biotech Campus ... life sciences campuses in the region's development pipeline.
Other Companies in Geneva
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $21.5M | 74 | 9% | N/A |
#2 | $16.7M | 74 | 0% | N/A |
#3 | $14M | 74 | 4% | N/A |
#4 | $15.3M | 75 | 53% | N/A |
#5 | N/A | 77 | 33% | N/A |